TRVN

Trevena Stock Price

1.505
-0.055 (-3.53%)
Upgrade to Real-Time
Regular Market
1.505

Low
1.43

52 Week Range

High
4.50

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.055 -3.53% 1.505 10:32:29
Open Price Low Price High Price Close Price Prev Close
1.56 1.495 1.56 1.56
Bid Price Ask Price Spread News
1.50 1.51 0.01 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
947 358,849 $ 1.52 $ 546,028 - 1.43 - 4.50
Last Trade Time Type Quantity Stock Price Currency
10:32:29 100 $ 1.505 USD

Period:

Draw Mode:

Trevena Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 247.59M 164.51M 163.34M $ 3.07M $ - -0.24 -6.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 443.03k 2.00%

more financials information »

Trevena News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TRVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.521.601.4651.531,158,889-0.015-0.99%
1 Month1.942.001.461.763,069,517-0.435-22.42%
3 Months1.702.201.431.772,639,193-0.195-11.47%
6 Months2.253.101.432.003,262,970-0.745-33.11%
1 Year1.994.501.432.335,338,785-0.485-24.37%
3 Years1.404.500.38231.893,099,3070.1057.5%
5 Years6.688.000.38232.032,154,425-5.18-77.47%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.


Your Recent History
NASDAQ
TRVN
Trevena
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.